MedPath

Clinical Study to Evaluate the Blood Triglyceride Decreasing Effect and Safety of Korean Post-Fermented Tea Extracts

Not Applicable
Completed
Conditions
Triglycerides High
Interventions
Dietary Supplement: Heukcha Extracts
Dietary Supplement: Placebo
Registration Number
NCT04850352
Lead Sponsor
Amorepacific Corporation
Brief Summary

This study was conducted to investigate the effects of daily supplementation of Korean Post-Fermented Tea(Heukcha) Extracts on improvement of Blood Triglyceride Level.

Detailed Description

This study was a 8 week, randomized, multicenter, double-blind, placebo-controlled, parallel-design human trial.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Male and female subjects older than 19 years old
  • Who has fasting blood triglyceride levels ≥ 150 mg/dL
  • Who voluntarily agreed to participate in the study and signed an informed consent form
Exclusion Criteria
  • Those who are taking functional food designed for dyslipidemia reduction within 4 weeks before study participation
  • Those who have been diagnosed and are on medication with dyslipidemia, cardiovascular disease, kidney disease, liver disease or thyroid disease within 4 weeks before study participation
  • Fasting plasma glucose >126 mg/dL or treatment with medications including oral hypoglycemic agents or insulin
  • Who has used or is expected to inevitably use prohibited concomitant medications during the study
  • Women who is pregnant /breast-feeding, or who has childbearing potential and does not use available contraceptives
  • Who has dosed other study medications within 30 days before screening
  • Who is determined ineligible for study participation by investigators for any other reasons

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Heukcha ExtractsHeukcha ExtractsTake Heukcha Extracts capsule once daily for 8 weeks.
PlaceboPlaceboTake placebo capsule once daily for 8 weeks.
Primary Outcome Measures
NameTimeMethod
Change in fasting triglyceridesBaseline, Week 4 and Week 8
Secondary Outcome Measures
NameTimeMethod
Change in total cholesterol, LDL-C, HDL-CBaseline, Week 4 and Week 8
Change in BMI (kg/m2)Baseline, Week 4 and Week 8
Change in Waist circumference (cm)Baseline, Week 4 and Week 8

Trial Locations

Locations (3)

St. Vincent's Hospital, College of Medicine, The Catholic University of Korea

🇰🇷

Suwon, Korea, Republic of

KangBuk Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Seoul National University

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath